Suppr超能文献

急性和慢性应激相关疾病中胍丁胺神经传递的研究进展。

Perspectives on Agmatine Neurotransmission in Acute and Chronic Stressrelated Conditions.

机构信息

Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Mini Rev Med Chem. 2023;23(15):1560-1574. doi: 10.2174/1389557523666230125104753.

Abstract

Adaptive responses to stressful stimuli in the environment are believed to restore homeostasis after stressful events. Stress activates the hypothalamic-pituitary-adrenocortical (HPA) axis, which releases glucocorticoids (GCs) into the bloodstream. Recently, agmatine, an endogenous monoamine was discovered to have the potential as a pharmacotherapy for stress. Agmatine is released in response to certain stress conditions, especially those involving GCs, and participates in establishing homeostasis disturbed by stress following GC activation. The therapeutic potential of agmatine for the management of psychological diseases involving stress and depression is promising based on a significant amount of literature. When exogenously applied, agmatine leads to reductions in levels of GCs and counteracts stress-related morphologic, synaptic, and molecular changes. However, the exact mechanism of action by which agmatine modifies the effects resulting from stress hormone secretion is not fully understood. This review aims to present the most possible mechanisms by which agmatine reduces the harmful effects of chronic and acute stress. Several studies suggest chronic stress exposure and repeated corticosteroid treatment lower agmatine levels, contributing to stress-related symptoms. Agmatine acts as an antistress agent by activating mTOR signaling, inhibiting NMDA receptors, suppressing iNOS, and maintaining bodyweight by activating α-2adrenergic receptors. Exogenous administration that restores agmatine levels may provide protection against stress-induced changes by reducing GCs release, stimulating anti-inflammatory processes, and releasing neuroprotective factors, which are not found in all therapies currently being used to treat stress-related disorders. The administration of exogenous agmatine should also be considered a therapeutic element that is capable of triggering a neural protective response that counters the effects of chronic stress. When combined with existing treatment strategies, this may have synergistic beneficial effects.

摘要

环境中应激刺激的适应性反应被认为是在应激事件后恢复体内平衡的机制。应激激活下丘脑-垂体-肾上腺皮质(HPA)轴,将糖皮质激素(GCs)释放到血液中。最近,发现内源性单胺胍丁胺有可能成为应激的药物治疗方法。胍丁胺在某些应激条件下释放,特别是涉及 GCs 的应激条件下释放,并参与在 GC 激活后建立由应激引起的体内平衡紊乱。基于大量文献,胍丁胺在管理涉及应激和抑郁的心理疾病方面具有很大的治疗潜力。当外源性应用时,胍丁胺会降低 GCs 的水平,并抵消与应激相关的形态、突触和分子变化。然而,胍丁胺修饰应激激素分泌产生的影响的确切作用机制尚未完全阐明。本综述旨在提出胍丁胺减轻慢性和急性应激有害影响的最可能机制。几项研究表明,慢性应激暴露和重复皮质类固醇治疗会降低胍丁胺水平,导致与应激相关的症状。胍丁胺通过激活 mTOR 信号、抑制 NMDA 受体、抑制 iNOS 和通过激活α-2肾上腺素能受体来维持体重,从而发挥抗应激作用。恢复胍丁胺水平的外源性给药可能通过减少 GCs 释放、刺激抗炎过程和释放神经保护因子来提供对应激诱导变化的保护,而目前用于治疗应激相关疾病的所有疗法都没有这些作用。外源性胍丁胺的给药也应被视为一种治疗元素,能够触发神经保护反应,抵消慢性应激的影响。当与现有的治疗策略结合使用时,这可能会产生协同的有益效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验